Over 200 Maryland Auctions End Tomorrow 02/08 - Bid Now
Over 2300 Total Lots Up For Auction at Four Locations - TX 02/10, CA 02/13, Ontario 02/14, NJ 02/17

The Neurotech Industry Investing and Partnering Conference 2009

by Lynn Shapiro, Writer | March 27, 2009
Moderator: Dan O'Connell, Managing Partner, NeuroVentures Capital

Neuroregeneration and Stem Cells:
Deborah Eppstein, President and CEO, Q Therapeutics
Andres Haegerstrand, Chief Scientific Officer, NeuroNova

Your Centrifuge Specialty Store

Quality remanufactured Certified Centrifuges at Great prices! Fully warranted and backed by a company you can trust! Call or click for a free quote today! www.Centrifugestore.com 800-457-7576


Jonathan Kil, President and CEO, Sound Pharmaceuticals
Martin McGlynn, President and CEO, StemCells, Inc.
Session Chair: Frank Eeckman, NeuroInsights, NIO

NeuroVaccines, The Use of Vaccines in Neurology and Psychiatry:
Raafat Fahim, President and CEO, Nabi
Mark Schwartz, President and CEO, Bayhill Therapeutics
Walter Schmidt, CEO, Affiris
Session Chair: Roger Quy, General Partner, Technology Partners

Traumatic Injury: Stroke, Traumatic Brain Injury, and Spinal Cord Injury:
Martin Dieck, President and CEO, Nfocus Neuromedical
Shawn Lunney, CEO, Neurolutions
Vincent Simmon, President and CEO, Xytis
Michael Singer, CEO, BrainScope
Session Chair: Teo Forcht Dagi, Partner, HLM Venture Partners

Neuroscience Translation, Tech Transfer and Collaboration Opportunities:
Jamie Driscoll, Chief of Research Services, NIMH
Jill Heemskerk, Acting Director, Office of Translational Research, NINDS
Joe Pancrazio, Program Director, Extramural, Repair & Plasticity Cluster,
NINDS Session Chair: Melissa Maderia, Technology Transfer Specialist, NINDS

And that's just for starters.

Back to HCB News